Christo, S. N., McDonald, K. M., Burn, T. N., Kurd, N., Stanfield, J., Kaneda, M. M., . . . Mackay, L. K. (2024). Dual CD47 and PD‐L1 blockade elicits anti‐tumor immunity by intratumoral CD8+ T cells. Clinical & Translational Immunology, 13(11), 1. https://doi.org/10.1002/cti2.70014
Chicago Style (17th ed.) CitationChristo, Susan N., et al. "Dual CD47 and PD‐L1 Blockade Elicits Anti‐tumor Immunity by Intratumoral CD8+ T cells." Clinical & Translational Immunology 13, no. 11 (2024): 1. https://doi.org/10.1002/cti2.70014.
MLA (9th ed.) CitationChristo, Susan N., et al. "Dual CD47 and PD‐L1 Blockade Elicits Anti‐tumor Immunity by Intratumoral CD8+ T cells." Clinical & Translational Immunology, vol. 13, no. 11, 2024, p. 1, https://doi.org/10.1002/cti2.70014.